The Kaolin Clotting Time of Platelet-Rich Plasma: A Test of Platelet Factor-3 Availability

1965 ◽  
Vol 11 (3) ◽  
pp. 258-268 ◽  
Author(s):  
R. M. Hardisty ◽  
R. A. Hutton
1981 ◽  
Author(s):  
M D Etherington ◽  
J R O’Brien

To investigate the relationship between the heparin neutralizing activity in platelets (intra-plat HNA = IP HNA) and in plasma (PPP HNA) as measured by the heparin thrombin clotting time (HTCT) and the plasma PF4 (PPP PF4) and the intra-platelet PF4 (IP PF4), we selected 15 people with contrasting amounts of HNA in their plasma; these included young and old controls, patients after operations and myocardial infarcts and pregnant women. Platelet rich plasma (PRP) and PPP were prepared from citrated blood processed entirely at 4°C. 2ml sub-samples of PRP and PPP were then frozen and thawed × 3, centrifuged and the supernatants collected. IP PF4 and PPP PF4 were measured by radioimmunoassay (ABBOTT KIT). To measure IP HNA and PPP HNA a modified Harada and Zucker clotting assay was performed. On each study day PPP was prepared from a control and used as substrate. All test plasmas were added to this PPP and the amount of heparin required to give a clotting time of 30 seconds was measured. IP HNA was calculated by subtraction of PPP units heparin from PRP units. The plasma fibrinogen was estimated by Clauss’ method.The IP PF4 was significantly correlated with IP HNA (r=0.95, n=15, p<0.001). The plasma PF4 in all volunteers was less than 10ng/ml-1 and bore no relation to the PPP HNA. However the plasma fibrinogen was significantly correlated to PPP HNA (r=0.91, n=15, p<0.001).Thus the IP HNA accurately reflects IP PF4 (with presumably a parallel small contribution from β-thromboglobulin). The PPP HNA, previously thought perhaps to reflect liberated PF4 or another intra-platelet anti-heparin substance, is now shown to be independent of PF4 but at least in part reflects the plasma fibrinogen (which neutralizes heparin). This quick and simple clotting assay is well suited to a routine laboratory and might be used to measure total IP HNA, and monitor the a granule content of platelets in disease.


1977 ◽  
Author(s):  
B. K. Kim ◽  
M.G. Baldini

Studies of early platelet changes caused by contact with artificial surfaces in a flow-system were done by the use of a bench-model of a hollow fiber (silicone rubber) mini-kidney. The artificial device contained 64 fibers in a polyurethane casing and was inserted in a silicone rubber circuit provided with a roller pump. Human platelet-rich plasma was used for perfusion. Perfusion for 60 m’ at a rate of 6 ml/m' caused no decrease in platelet count and no visible thrombus formation in the fibers. However, after perfusion for 5 m' there was a significant increase in ADP induced platelet aggregation with values of 75 ± 10% (control 56 ± 5.8%). The values rose to 80 ± 8.5% after 30 m' of perfusion. Collagen induced platelet aggregation also increased with values of 81 ± 9.3% (control 67 ± 5.3%) after 5 m' and 82 ± 6.3% after 30 m'. Platelet F3 availability measured by the Kaolin clotting time was 108 ± 5.5 sec before perfusion and became progressively enhanced during perfusion. The Kaolin clotting time became 93 ± 2.9 sec after 5m’, 84 ± 1.7 sec after 15 m', 76 ± 3.3 sec after 30 m' and 71 ± 3.7 sec after 60 m'. Platelet release of 14C-serotonin was only 2% to 3% after 60 m' perfusion. The content of purine nucleoside Phosphorylase (a cytoplasmic enzyme) and of β-glucuronidase (a lysosomal enzyme) detected in the plasma medium after 60m’ perfusion were only 1% to 2% of the respective platelet enzyme activity. It was concluded that contact with silicone rubber surfaces during short-time perfusion of hollow fibers caused significant platelet activation with enhancement of platelet aggregability and platelet F3 availability in the absence of significant degrees of release reaction.


1973 ◽  
Vol 30 (02) ◽  
pp. 299-306 ◽  
Author(s):  
S Renaud ◽  
P Gautheron

SummaryAs evaluated in a recording “coagulometer” the Stypven time of 16 to 19 days pregnant Holtzman rats was shorter than that of the controls solely in platelet-rich plasma but not in platelet-poor plasma collected in siliconized material when most of the platelets were removed by slow speed centrifugation (1000 G × 20 minutes). If the same blood was centrifuged at a higher speed (2000 G) the Stypven time was considerably shorter in the pregnant rats even if no platelets were left indicating that platelet factor 3 had been released in plasma during centrifugation.Identical results were obtained in 10 women taking oral contraceptives as compared to 10 controls. Depending on whether blood was collected in siliconized glassware or not, and final determination performed in plastic or glass, the cephalin clotting time of oral contraceptives treated women was found to be longer, equal or shorter than this of the controls. When it was shorter, a comparable reduction in the Stypven time indicated that the shortening was probably due to “release” of platelet factor 3 in the platelet-poor plasma, in the course of its preparation.


1971 ◽  
Vol 26 (03) ◽  
pp. 576-587
Author(s):  
R. D Mac Kenzie ◽  
T. R Blohm

SummaryWhen AN 162 was added to human citrated platelet-rich plasma at 30-300 µg/ml, it inhibited platelet aggregation induced by adenosine diphosphate, collagen, and thrombin. When AN 162 was given orally to guinea pigs at 30 to 100 mg/kg, an in vivo inhibitory effect on platelet aggregability was found. Though it activated platelet factor 3, the concentration of AN 162 required for substantial activation was greater than that for inhibition of platelet aggregation. No effect on plasma clotting factors was found at or below 300 µg/ml. Slight prolongation of whole blood clotting time was found in the rat and monkey.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3699-3699
Author(s):  
Wenche Jy ◽  
Joaquin J. Jimenez ◽  
Lawrence L. Horstman ◽  
Lucia M. Mauro ◽  
Carlos Bidot ◽  
...  

Abstract Introduction: PMP, EMP and LMP are known to be sensitive markers of thrombotic and inflammatory disorders, but their respective functional activities are obscure. Recent data indicate that these microparticles (MP) possess procoagulant, proaggregatory, and proinflammatory activities. In this study, we have compared these activities in MP derived from different cells. Methods: PMP were prepared by stimulating platelet-rich plasma with 10 μM ADP plus 5 μg/mL collagen. EMP were prepared by incubating renal endothelial cells (EC) with 10 ng/mL of TNF-α for 24 hrs. LMP were prepared by incubating U937 monocytic cells or neutrophils with 10 ng/mL LPS for 1 hr. Cells were removed by centrifugation (1000xg for 10 min), MP were sedimented (15,000xg for 30 min), pellets were washed twice, then resuspended to equal MP concentration (1 x 108 counts/μL, final concentration) based on counts by flow cytometry. The MP were then tested for (ia) tissue factor (TF) antigen expression (TF:Ag) by flow cytometry, (ib) TF activity by recalcified clotting time in presence of corn trypsin inhibitor, (ii) platelet factor 3 (PF3) procoagulant activity by RVVT [Thromb Res 80:471, 1995], (iii) von willebrand factor (vWF)-dependent platelet aggregating activity by a ristocetin flow cytometric method [J Thromb Haemost 3:1301, 2005], and (iv) binding of MP to leukocytes, induced expression of CD11b and enhanced transendothelial migration (TEM) [Front Biosci 9:3137, 2004]. Results: In vivo, we found that the relative abundance of PMP, EMP, and LMP numbers in normal plasma is 50–70%, 5–10%, and 5–15% of total MP, respectively. In vitro results were as follows: (i) LMP exhibited the highest TF:Ag per MP followed by EMP, >PMP. However, PMP produced the shortest recalcified clotting time, indicating PMP had the highest apparent TF activity. (ii) PF3 activity was highest in PMP, followed by EMP, > LMP. In view of the abundance of circulating PMP (50–70% of total MP), it appears that PMP are mainly responsible for hemostatic activity in cell-free coagulation. (iii) On the other hand, EMP had the highest specific activity in promoting vWF-dependent platelet aggregation, > PMP, > LMP. (iv) Both PMP and EMP showed high affinity in binding monocytes and neutrophils, and inducing expression of CD11b, as well as promoting TEM. LMP had little effect on leukocyte activation. Discussion: Our results show that MP of different cell origins have distinctive activities in promoting coagulation, platelet aggregation, leukocyte activation, and TEM. These differences may reflect their distinctive membrane compositions. Overall, PMP and EMP seem to play more active roles in hemostasis and inflammation, as judged by these measures. Since LMP expressed the highest TF:Ag, they may serve to initiate coagulation during leukocyte activation. But their net procoagulant and proinflammatory activities are relatively small. A better understanding of the functional activities of the growing number of recognized MP species is expected to provide new insights on their roles in hemostasis and inflammation.


1990 ◽  
Vol 64 (03) ◽  
pp. 478-484 ◽  
Author(s):  
Thomas Exner ◽  
Douglas A Triplett ◽  
David A Taberner ◽  
Margaret A Howard ◽  
E Nigel Harris

SummarySix lyophilized plasma samples were sent to 20 “expert” laboratories for assessment of lupus anticoagulant (LA). Four samples contained pooled LA of graded potency mixed with aged normal plasma. One contained LA plus cephalin phospholipid and one contained a nonspecific venom anticoagulant. Sixteen methods were used overall with some participants using up to 8 methods. Results were scored in regard to the known potencies of LA in the samples and other known induced defects.Activated partial thromboplastin time (APTT) tests used by most participants for preliminary screening were relatively sensitive, but non-specific. Platelet or phospholipid neutralization procedures (PNP) appeared to be sensitive and specific but showed a non-linear response to increased LA content. Kaolin clotting time (KCT) tests showed the most sensitive response to increased LA content but the weaker LA were not scored as abnormal by most laboratories as the samples may have contained platelet fragments. Other commonly used tests such as the tissue thromboplastin inhibition (TTI) test and the dilute Russell’s viper venom test (DRVVT) were carried out somewhat inconsistently. The variability in performance of tests in different laboratories indicates that standardization of methodology is urgently required.Generally it seemed that most clotting tests were “bypassed” by the addition of phospholipid to a known LA-positive sample in apparently direct proportion to their sensitivity. Sample preparation, especially prevention of contamination with activated platelets is a vital preliminary part in the assay of LA.


1991 ◽  
Vol 66 (02) ◽  
pp. 213-217 ◽  
Author(s):  
Arthur P Bode ◽  
William J Castellani ◽  
Edna D Hodges ◽  
Susan Yelverton

SummaryThe effect of lysed platelets on the activated coagulation time (ACT) was studied in heparinized whole blood during titration with protamine. Frozen-thawed washed platelet suspension, or a chromatography fraction thereof, or autologous frozen-thawed platelet-rich plasma was added in various dilutions to freshly drawn blood anticoagulated with 3,000 USP units/1 heparin. After a 10 min incubation, the amount of protamine needed to restore the ACT to baseline ("protamine titration dose") was determined. We found that the protamine titration dose decreased in proportion to the amount of lysed platelet material added; expressed as a percentage of the total number of platelets present, each unit increase in lysed platelets produced a 1.7% ±0.8 (SD) reduction in the protamine dose needed to normalize the ACT. A heparin activity assay showed that this effect was not due to antiheparin activity of lysed platelets such as platelet factor 4 (PF4). Our data indicate that the procoagulant activity of platelet membranes reduced the sensitivity of the ACT to heparin. These findings suggest that membranous platelet microparticles may cause an inaccurate calculation, based on the ACT, of a protamine dose to reverse heparin anticoagulation in cardiopulmonary bypass procedures.


1973 ◽  
Vol 30 (01) ◽  
pp. 093-105 ◽  
Author(s):  
C.H.J Sear ◽  
L Poller ◽  
F.R.C Path

SummaryThe antiheparin activity of normal serum has been studied by comparing the antiheparin activities of sera obtained from normal whole blood, platelet-rich plasma and platelet-’free’ plasma with a purified platelet extract during differential isoelectric precipitation and by gel filtration chromatography.The mean values for the activity of PRP-serum and PFP-serum were 106% (S.D. 11) and 10% (S.D. 3) of untreated whole blood respectively. The activity of whole blood serum, PRP serum and whole blood serum plus platelet extract precipitated under identical physical conditions, i.e. pH 7.0, I =0.008, indicating that the activities of the three samples are probably associated with PF4. PF4 precipitated from human platelet extract at pH 4.0, but this is probably due to the difference in the two biochemical environments investigated, i.e. serum and platelet extract.The gel filtration experiments revealed striking similarities between the major antiheparin activities of serum and platelet extract. At physiological pH and ionic strength both activities were associated with high molecular weight material, but at physiological pH and elevated ionic strength both activities behaved as much smaller entities of molecular weight between 25,000 and 30,000 daltons and it seems very likely that both activities are associated with the same molecule, i.e. PF4.


1964 ◽  
Vol 11 (02) ◽  
pp. 506-512 ◽  
Author(s):  
V. A Lovric ◽  
J Margolis

SummaryAn adaptation of “kaolin clotting time” and prothrombin time for use on haemolysed capillary blood provided simple and sensitive screening tests suitable for use in infants and children. A survey of three year’s experience shows that these are reliable routine laboratory tests for detection of latent coagulation disorders.


1984 ◽  
Vol 51 (01) ◽  
pp. 037-041 ◽  
Author(s):  
K M Weerasinghe ◽  
M F Scully ◽  
V V Kakkar

SummaryCollagen mediated platelet aggregation caused -5.6 ± 6.7% inhibition and +39.1 ± 15.2% potentiation of prekallikrein activation in plasma from normal healthy volunteers between 20–40 and 50–65 years of age, respectively (n = 15, p <0.01). The amouns of platelet factor-four (PF4) released in the two groups were not significantly different. Collagen treatment in the presence of indomethacin caused +11.5 ± 3.6% and +59.6 ± 19.5% potentiation in the 20–40 and 50–65 age groups respectively (p <0.02). Adrenaline mediated platelet aggregation caused -55.2 ± 7.1% and -35.2 ± 8.3% inhibition in the 20–40 and 50–65 age groups, respectively. Collagen treatment of platelet-deficient-plasma and platelet-rich-plasma in EDTA also caused potentiation of prekallikrein activation.The results indicate that the observed degree of prekallikrein activation after platelet aggregation is a net result of the inhibitory effect of PF4 and the potentiatory effect of activated platelets. The potentiatory effect was greater after collagen treatment as compared to adrenaline treatment, and in the 50–65 age group as compared to the 20–40 age group.


Sign in / Sign up

Export Citation Format

Share Document